Get the latest tech news

A Game-Changing Drug for Pancreatic Cancer Just Got FDA Approval

In a large-scale clinical trial, people taking daraxonrasib lived twice as long as those given standard chemotherapy.

None

Related news:

FDA approves first in class targeted therapy for metastatic pancreatic cancer

FDA approves world’s first dual-sensor CGM in diabetes 'breakthrough' — new Libre Duo sensor tracks ketones and blood sugar in real-time

Rockstar calls GTA 6 leaks 'heartbreaking for our team' and says the game is nearly finished